(VHT) Vanguard Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US92204A5048 • Health
VHT: Health, Care, Stocks, Companies, Medicines, Drugs
The Vanguard Health Care Index Fund ETF Shares (VHT) is a passively managed exchange-traded fund designed to provide exposure to the U.S. healthcare sector by tracking the performance of a market-capitalization-weighted index. The fund seeks to replicate the returns of the MSCI US Investable Market Health Care 25/50 Index, which includes a broad range of U.S. healthcare companies across various market caps, from large-cap to small-cap firms. This structure allows investors to gain diversified exposure to the entire healthcare value chain, including pharmaceuticals, biotechnology, medical devices, healthcare providers, and life sciences companies.
As a passive investment vehicle, VHT aims to hold a portfolio of stocks that closely mirrors the composition and weighting of its target index. The fund typically invests at least 95% of its assets in securities included in the index, ensuring high fidelity to its benchmark. This approach minimizes active management risk and keeps operating expenses low, with a current expense ratio of 0.10%. The ETFs structure also provides transparency, as its holdings are disclosed daily, and liquidity, given its listing on the NYSE ARCA exchange.
With over $17 billion in assets under management, VHT is one of the largest and most liquid healthcare-focused ETFs available to investors. Its diversified portfolio spans multiple subsectors within healthcare, offering exposure to both established players and innovative disruptors. This makes it a popular choice for investors seeking to capitalize on long-term demographic trends such as an aging population, increased healthcare spending, and advancements in medical technology. However, like all sector-specific funds, VHT comes with heightened exposure to industry-specific risks, including regulatory changes, drug pricing pressures, and clinical trial outcomes.
Additional Sources for VHT ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VHT ETF Overview
Market Cap in USD | 17,003m |
Category | Health |
TER | 0.10% |
IPO / Inception | 2004-01-26 |
VHT ETF Ratings
Growth 5y | 65.1% |
Fundamental | - |
Dividend | 57.3% |
Rel. Strength Industry | -8.51 |
Analysts | - |
Fair Price Momentum | 263.81 USD |
Fair Price DCF | - |
VHT Dividends
Dividend Yield 12m | 1.46% |
Yield on Cost 5y | 2.76% |
Annual Growth 5y | 7.36% |
Payout Consistency | 96.0% |
VHT Growth Ratios
Growth Correlation 3m | 73.4% |
Growth Correlation 12m | 27.9% |
Growth Correlation 5y | 81.3% |
CAGR 5y | 13.24% |
CAGR/Max DD 5y | 0.75 |
Sharpe Ratio 12m | -0.52 |
Alpha | -7.12 |
Beta | 0.48 |
Volatility | 12.93% |
Current Volume | 150.1k |
Average Volume 20d | 228k |
As of March 14, 2025, the stock is trading at USD 261.62 with a total of 150,060 shares traded.
Over the past week, the price has changed by -3.61%, over one month by -2.83%, over three months by +0.82% and over the past year by -0.98%.
Yes. Based on ValueRay Analyses, Vanguard Health Care (NYSE ARCA:VHT) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 65.14 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VHT as of March 2025 is 263.81. This means that VHT is currently overvalued and has a potential downside of 0.84%.
Vanguard Health Care has no consensus analysts rating.
According to ValueRays Forecast Model, VHT Vanguard Health Care will be worth about 290.1 in March 2026. The stock is currently trading at 261.62. This means that the stock has a potential upside of +10.89%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 290.1 | 10.9% |